Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / disclosure-schedules-to-npa.docx
disclosure-schedules-to-npa.docx
Parties
AGREEMENT Genome Dx Therapeutics Inc
Genome Dx Therapeutics Inc
Harkness LLP
General Corp
Delaware General Corp
Equity Inc
The Delaware General Corp
Employee Retirement Inc
Dates
April 9, 2024
March 14, 2017
April 3, 2017
April 5, 2024
January 15, 2024
February 8, 2024
December 31, 2023
Amounts
$40,000,000
$0.0001
$1.87
$4.15
$95,000,000
$5,800,000
$69,600,000
$22,000,000
$18,700,000
$74,100,000
Obligations
Capitalized terms used but not otherwise defined in these Schedules shall have the meanings ascribed to such terms in the Agreement
The Company has endeavored to include cross-references where applicable, but the absence of a cross-reference shall not be deemed to limit the applicability of any disclosure to any other representation, warranty, covenant, or agreement in the Agreement
The inclusion of any item, matter, or information in these Schedules does not constitute an admission by the Company that such item, matter, or information is material, that such item, matter, or information would reasonably be expected to result in a Material Adverse Effect, or that such item, matter, or information is required to be disclosed under the terms of the Agreement
Items and information may be included in these Schedules solely for informational purposes or out of an abundance of caution, and such inclusion shall not be deemed to set a standard of materiality or to broaden or otherwise affect the scope of any representation or warranty contained in the Agreement
The headings and section references contained in these Schedules are inserted for convenience of reference only and shall not affect the meaning or interpretation of these Schedules or the Agreement
In the event of any inconsistency between these Schedules and the Agreement, the terms and conditions of the Agreement shall control